Drug Profile
Somatropin long-acting - Delpor
Alternative Names: DLP-202; hGH - Delpor; Human growth hormone - DelporLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Delpor
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Somatotropin deficiency
Highest Development Phases
- No development reported Somatotropin deficiency
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Somatotropin-deficiency in USA (SC, Implant)
- 15 Aug 2016 Somatropin long-acting - Delpor is available for licensing as of 15 Aug 2016. http://www.delpor.com/
- 15 Aug 2016 Early research in Somatotropin deficiency in USA (SC)